Gary Crump, MD
Rheumatology · Louisville, KYNPI 1285709386
Payments from drug & device makers
Across 1,483 payments — averaging $118.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$91K
- AbbVie$31K
- Novartis$25K
- UCB, Inc.$16K
- Johnson & Johnson$4K
- AstraZeneca$1K
- plus $8K from 28 others
What the payments were for
- Consulting fees$20,64112%
- Speaking & faculty fees$106,74461%
- Travel & lodging$14,6428%
- Food & beverage$33,23519%
- Education$4300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 406 | $90,903 |
| AbbVie | 196 | $31,195 |
| Novartis | 109 | $24,694 |
| UCB, Inc. | 157 | $15,682 |
| Johnson & Johnson(2 entities) | 152 | $3,772 |
| AstraZeneca(2 entities) | 61 | $1,446 |
| Mallinckrodt Hospital Products Inc. | 40 | $1,423 |
| E.r. Squibb & Sons, L.L.C. | 72 | $1,002 |
| Boehringer Ingelheim | 31 | $951 |
| Pfizer | 58 | $800 |
| GSK | 33 | $527 |
| Regeneron Healthcare Solutions, Inc. | 22 | $518 |
| Lilly USA, LLC | 22 | $396 |
| ANI Pharmaceuticals, Inc. | 20 | $373 |
| Sanofi | 11 | $263 |
| Radius Health, Inc. | 15 | $226 |
| Genentech USA, Inc. | 11 | $180 |
| Pacira Therapeutics, Inc. | 10 | $164 |
| Sandoz | 8 | $163 |
| Bristol Myers Squibb | 9 | $142 |
| Aurinia Pharma U.S., Inc. | 7 | $128 |
| Bayer | 1 | $123 |
| Organon | 8 | $114 |
| Mallinckrodt Enterprises LLC | 5 | $96 |
| Sobi, Inc | 5 | $96 |
| Ultragenyx Pharmaceutical Inc. | 1 | $61 |
| Genentech, Inc. | 1 | $50 |
| Merck | 3 | $37 |
| Antares Pharma, Inc. | 2 | $36 |
| Actelion Pharmaceuticals US, Inc. | 1 | $33 |
| Orthogenrx Inc. | 2 | $32 |
| Fresenius Kabi USA, LLC | 1 | $29 |
| Hikma Pharmaceuticals USA | 2 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$175,691 in reported general payments places this provider in the 85th percentile of 81 rheumatology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RinvoqUpadacitinib | 44 | $329,904 |
| Humira(Cf) PenAdalimumab | 21 | $244,192 |
| Humira PenAdalimumab | 21 | $165,087 |
| Orencia ClickjectAbatacept | 21 | $161,327 |
| Enbrel SureclickEtanercept | 14 | $159,537 |
| Enbrel MiniEtanercept | 12 | $89,022 |
| MethotrexateMethotrexate Sodium | 278 | $7,654 |
| Hydroxychloroquine Sulfate | 220 | $7,158 |
| Pilocarpine Hcl | 44 | $4,880 |
| Celecoxib | 107 | $2,970 |
| Colchicine | 50 | $2,857 |
| Cevimeline Hcl | 13 | $2,521 |
| Leflunomide | 53 | $1,836 |
| Febuxostat | 47 | $1,702 |
| Allopurinol | 159 | $1,237 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $31,195 | $329,90444 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 81 rheumatology providers in Kentucky.
Other rheumatology in Louisville
- Housam SarakbiLouisville$297K
- Benjamin BooneLouisville$80K
- Jacquelyn SmithLouisville$63K
- Lisa JuneLouisville$27K
- Carolyn GleasonLouisville$25K
- Janet LeonLouisville$20K
- Steven SternLouisville$3K
- Heidi RogersLouisville$2K
- Mohamed JallohLouisville$2K
- Ami JoglekarLouisville$830
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.